Adult Hematology Abstract CategoriesMyeloma OP 04
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VERSUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA (IKEMA): FINAL OVERALL SURVIVAL ANALYSIS
Ecenur Guder Arslan1, Kwee Yong2, Thomas Martın3, Meletios Dımopoulos4, Joseph Mıkhael5, Marcelo Capra6, Thierry Facon7, Roman Hájek8, Ivan Špıčka9, Ross Baker10, Kihyun Kım11, Gracia Martınez12, Chang-Ki Mın13, Philippe Moreau14
1 Sanofi
2 University College London Cancer Institute
3 University of California
4 National and Kapodistrian University of Athens
5 Translational Genomics Research Institute (TGen), City of Hope Cancer Center
6 Hospital Mãe de Deus
7 Lille University Hospital
8 Department of Hematooncology, University of Ostrava
9 1st Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague
10 Murdoch University
11 Sungkyunkwan University Samsung Medical Center
12 Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
13 Department of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea
14 University Hospital Hôtel-Dieu
Ver másRead
1149
Timeswas read the article
575
Total PDF
574
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 56 | 24 | 80 |
| 2025 6 | 34 | 30 | 64 |
| 2025 5 | 38 | 23 | 61 |
| 2025 4 | 36 | 19 | 55 |
| 2025 3 | 43 | 12 | 55 |
| 2025 2 | 30 | 24 | 54 |
| 2025 1 | 34 | 22 | 56 |
| 2024 12 | 18 | 22 | 40 |
| 2024 11 | 35 | 22 | 57 |
| 2024 10 | 15 | 31 | 46 |
| 2024 9 | 20 | 31 | 51 |
| 2024 8 | 23 | 41 | 64 |
| 2024 7 | 14 | 17 | 31 |
| 2024 6 | 23 | 30 | 53 |
| 2024 5 | 24 | 30 | 54 |
| 2024 4 | 14 | 25 | 39 |
| 2024 3 | 18 | 27 | 45 |
| 2024 2 | 21 | 25 | 46 |
| 2024 1 | 23 | 18 | 41 |
| 2023 12 | 13 | 25 | 38 |
| 2023 11 | 21 | 32 | 53 |
| 2023 10 | 21 | 45 | 66 |
Show all
